On March 20, 2009, the World Trade Organization (WTO) Dispute Settlement Body adopted the report of the dispute settlement panel in China â Measures Affecting the Protection and Enforcement of Intellectual Property Rights (China â IPR). The report addressed three claims brought by the United States alleging that certain Chinese measures are inconsistent with the WTO Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS).
On July 17, 2007, Rwanda notified the World Trade Organization's (WTO) Council for Trade-Related Aspects of Intellectual Property Rights (TRIPS) that it plans to import the HIV-drug TriAvir from the Canadian company Apotex and will not enforce any patents granted in that respect in Rwanda. Two months later, Canada issued a compulsory license allowing Apotex to use nine patented inventions for manufacturing and exporting TriAvir to Rwanda.
On February 7, 2006, a panel of the World Trade Organization (WTO) circulated its draft report on the high-profile dispute European Communities ? Measures Affecting the Approval and Marketing of Biotech Products to the parties. In May 2003, Argentina, Canada and the United States (US) had requested the establishment of a Panel because consultations with the EC on an amicable solution had failed.